Published in AJR Am J Roentgenol on July 01, 2009
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Am J Gastroenterol (2015) 1.44
Prospective evaluation of MR enterography as the primary imaging modality for pediatric Crohn disease assessment. AJR Am J Roentgenol (2011) 1.20
Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis. World J Gastroenterol (2012) 1.16
CT enterography: review of technique and practical tips. Br J Radiol (2012) 1.10
Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations. J Pediatr Gastroenterol Nutr (2012) 1.10
Mucosal healing in inflammatory bowel disease-a true paradigm of success? Gastroenterol Hepatol (N Y) (2012) 1.08
MR motility imaging in Crohn's disease improves lesion detection compared with standard MR imaging. Eur Radiol (2010) 1.04
MRI diffusion-weighted imaging (DWI) in pediatric small bowel Crohn disease: correlation with MRI findings of active bowel wall inflammation. Pediatr Radiol (2013) 1.03
Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease. Therap Adv Gastroenterol (2011) 0.99
Magnetic resonance enterography in Crohn's disease: Standard and advanced techniques. World J Radiol (2010) 0.96
MRI in patients with inflammatory bowel disease. J Magn Reson Imaging (2011) 0.95
MR enterography versus capsule endoscopy in paediatric patients with suspected Crohn's disease. Eur Radiol (2010) 0.93
Measuring disease activity in Crohn's disease: what is currently available to the clinician. Clin Exp Gastroenterol (2014) 0.92
Detecting active inflammation and fibrosis in pediatric Crohn's disease: prospective evaluation of MR-E and CT-E. Abdom Imaging (2013) 0.90
MRI in Crohn's disease--current and future clinical applications. Nat Rev Gastroenterol Hepatol (2011) 0.88
Magnetic resonance enterography: safe and effective imaging for stricturing Crohn's disease. Dig Dis Sci (2011) 0.87
CT enterography of pediatric Crohn disease. Pediatr Radiol (2009) 0.83
Computed tomography enterography and magnetic resonance enterography in the diagnosis of Crohn's disease. Intest Res (2015) 0.83
Outcomes of computed tomography and magnetic resonance enterography in clinical practice of inflammatory bowel disease. Dig Dis Sci (2013) 0.83
Newer CT applications and their alternatives: what is appropriate in children? Pediatr Radiol (2011) 0.83
Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn's disease. Dig Dis Sci (2013) 0.83
Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease. Gut (2011) 0.82
Small bowel endoscopy in inflammatory bowel disease. Clin Endosc (2013) 0.80
18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn's disease. Dig Dis Sci (2012) 0.80
Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies. Inflamm Bowel Dis (2013) 0.79
Recent trends in diagnostic techniques for inflammatory bowel disease. Korean J Intern Med (2015) 0.79
Grading of Crohn's disease activity using CT, MRI, US and scintigraphy: a meta-analysis. Eur Radiol (2015) 0.79
Inflammatory bowel disease imaging: Current practice and future directions. World J Gastroenterol (2016) 0.78
Role of computed tomography enterography/magnetic resonance enterography: is it in prime time? Clin Endosc (2012) 0.78
Comparison of 3% sorbitol vs psyllium fibre as oral contrast agents in MR enterography. Br J Radiol (2014) 0.78
A prospective randomized controlled study of erythromycin on gastric and small intestinal distention: implications for MR enterography. Eur J Radiol (2014) 0.78
Comparison of magnetic resonance enterography, capsule endoscopy and gastrointestinal radiography of children with small bowel Crohn's disease. Exp Ther Med (2013) 0.77
Chronic inflammatory diseases of the bowel: diagnosis and follow-up. Pediatr Radiol (2010) 0.77
A look into the small bowel in Crohn's disease. Clin Endosc (2012) 0.76
Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease. Am J Gastroenterol (2016) 0.76
Magnetic Resonance Imaging of the Small Bowel in Crohn's Disease: A Systematic Review and Meta-Analysis. Can J Gastroenterol Hepatol (2016) 0.75
The Role of MR Enterography in Assessing Crohn's Disease Activity and Treatment Response. Gastroenterol Res Pract (2015) 0.75
Effects of oral contrast on dose in abdominopelvic computed tomography with pure iterative reconstruction. World J Radiol (2016) 0.75
Diagnostic imaging and radiation exposure in inflammatory bowel disease. World J Gastroenterol (2016) 0.75
Imaging of the small bowel: Crohn's disease in paediatric patients. World J Radiol (2014) 0.75
Magnetic resonance enterography: A stepwise interpretation approach and role of imaging in management of adult Crohn's disease. Indian J Radiol Imaging (2016) 0.75
Getting the steak without the sizzle: is MR enterography as good as CT enterography? Inflamm Bowel Dis (2010) 0.75
Magnetic resonance enterography in refractory iron deficiency anemia: a pictorial overview. World J Gastroenterol (2014) 0.75
Using computed tomography enterography to evaluate patients with Crohn's disease: what impact does examiner experience have on the reproducibility of the method? Radiol Bras (2017) 0.75
Digestive-tract sarcoidosis: French nationwide case-control study of 25 cases. Medicine (Baltimore) (2016) 0.75
Difference between enterography and enteroclysis. AJR Am J Roentgenol (2010) 0.75
Computed Tomography and Magnetic Resonance Enterography in Crohn's Disease: Assessment of Radiologic Criteria and Endpoints for Clinical Practice and Trials. Inflamm Bowel Dis (2016) 0.75
Using CT and MR Enterography to Diagnose and Monitor IBD. Gastroenterol Hepatol (N Y) (2010) 0.75
Endoscopy and cross-sectional imaging for assessing Crohn׳s disease activity. Tech Gastrointest Endosc (2016) 0.75
Semi-automatic bowel wall thickness measurements on MR enterography in patients with Crohn's disease. Br J Radiol (2017) 0.75
Comparison of CT enterography and MR enterography imaging features of active Crohn disease in children and adolescents. Pediatr Radiol (2017) 0.75
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med (2005) 14.50
Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med (2010) 12.35
Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics (2008) 12.10
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med (2008) 9.32
Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med (2004) 7.93
Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med (2007) 7.82
Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet (2007) 7.81
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology (2006) 6.88
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology (2006) 6.36
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Gut (2011) 6.08
Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol (2007) 5.77
Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med (2013) 4.75
Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med (2007) 4.56
Crohn's disease. Lancet (2012) 4.42
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol (2006) 4.18
Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol (2011) 3.97
Management of Crohn's disease in adults. Am J Gastroenterol (2009) 3.94
The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol (2011) 3.92
Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis (2007) 3.83
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology (2006) 3.68
Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology (2008) 3.52
The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology (2004) 3.50
Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology (2007) 3.44
Incidental findings in imaging research: evaluating incidence, benefit, and burden. Arch Intern Med (2010) 3.40
Ulcerative colitis. Lancet (2012) 3.38
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial. Gastroenterology (2007) 3.32
An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol (2008) 3.30
Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study. Gastroenterology (2013) 3.28
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology (2003) 3.22
MR elastography of the liver: preliminary results. Radiology (2006) 3.20
Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol (2007) 3.14
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. JAMA (2008) 3.09
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology (2011) 2.96
Assessing attitudes toward laxative preparation in colorectal cancer screening and effects on future testing: potential receptivity to computed tomographic colonography. Mayo Clin Proc (2007) 2.95
Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA (2005) 2.92
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology (2003) 2.89
Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry. Am J Gastroenterol (2012) 2.88
Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87
Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc (2007) 2.82
Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT. Acad Radiol (2007) 2.80
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology (2002) 2.78
Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology (2007) 2.76
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol (2010) 2.74
Agreement between patient reports of cardiovascular disease and patient medical records. Mayo Clin Proc (2005) 2.71
The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol (2009) 2.70
Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol (2009) 2.69
Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease. Am J Gastroenterol (2010) 2.55
Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis (2010) 2.54
Extracolonic findings at CT colonography: evaluation of prevalence and cost in a screening population. Gastroenterology (2003) 2.54
Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc (2014) 2.52
5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest (2009) 2.45
Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy. Clin Gastroenterol Hepatol (2012) 2.41
Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol (2008) 2.41
Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol (2013) 2.39
High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol (2011) 2.38
Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am (2002) 2.37
Once-daily, high-concentration MMX mesalamine in active ulcerative colitis. Gastroenterology (2006) 2.34
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis (2005) 2.32
A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximab. Clin Gastroenterol Hepatol (2013) 2.31
Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc (2008) 2.30
Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology (2008) 2.26
CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics (2006) 2.21
Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis (2010) 2.20
Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis (2014) 2.19
Asthma and proinflammatory conditions: a population-based retrospective matched cohort study. Mayo Clin Proc (2012) 2.17
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol (2008) 2.15
Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol (2007) 2.15
A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research. Inflamm Bowel Dis (2014) 2.09
Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli. J Clin Microbiol (2013) 2.09
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis. Gastroenterology (2013) 2.04